We previously reported that
l-Cysteine, an H2S donor, significantly alleviated
brain injury after
hypoxia-ischemic (HI) injury in neonatal mice. However, the mechanisms underlying this
neuroprotective effect of
l-Cysteine against HI insult remain unknown. In the present study, we tested the hypothesis that the protective effects of
l-Cysteine are associated with glial responses and autophagy, and
l-Cysteine attenuates synaptic injury as well as behavioral deficits resulting from HI. Consistent with our previous findings, we found that treatment with
l-Cysteine after HI reduced early
brain injury, improved behavioral deficits and synaptic damage, effects which were associated with an up-regulation of
synaptophysin and
postsynaptic density protein 95 expression in the lesioned cortex.
l-Cysteine attenuated the accumulation of CD11b+/CD45high cells, activation of microglia and astrocytes and diminished HI-induced increases in
reactive oxygen species and
malondialdehyde within the lesioned cortex. In addition,
l-Cysteine increased
microtubule associated protein 1 light chain 3-II and
Beclin1 expression, decreased p62 expression and phosphor-
mammalian target of rapamycin and phosphor-
signal transducer and activator of transcription 3. Further support for a critical role of
l-Cysteine was revealed from results demonstrating that treatment with an inhibitor of the H2S-producing
enzyme, amino-oxyacetic
acid, reversed the beneficial effects of
l-Cysteine described above. These results demonstrate that
l-Cysteine effectively alleviates HI injury and improves behavioral outcomes by inhibiting reactive glial responses and synaptic damage and an accompanying triggering of autophagic flux. Accordingly,
l-Cysteine may provide a new a therapeutic approach for the treatment of HI via the formation of H2S.